132 related articles for article (PubMed ID: 1933055)
1. Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.
Weisdorf DJ; Haake R; Miller WJ; McGlave PB; LeBien TW; Vallera DA; Lasky LC; Kim TH; Peterson BA; Ramsay NK
Bone Marrow Transplant; 1991 Aug; 8(2):135-42. PubMed ID: 1933055
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
3. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
[TBL] [Abstract][Full Text] [Related]
5. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO.
Conde E; Sierra J; Iriondo A; Domingo A; García Laraña J; Marín J; Caballero D; Martínez F; León A; García-Conde J
Bone Marrow Transplant; 1994 Aug; 14(2):279-86. PubMed ID: 7994243
[TBL] [Abstract][Full Text] [Related]
8. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
[TBL] [Abstract][Full Text] [Related]
9. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
11. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K; Margolin K; Champlin R; Forman S
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
13. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.
Cervantes F; Shu XO; McGlave PB; Ramsay NK; Miller WJ; Kersey JH; Weisdorf DJ
Bone Marrow Transplant; 1995 Sep; 16(3):387-92. PubMed ID: 8535311
[TBL] [Abstract][Full Text] [Related]
15. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
16. CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Soiffer RJ; Freedman AS; Neuberg D; Fisher DC; Alyea EP; Gribben J; Schlossman RL; Bartlett-Pandite L; Kuhlman C; Murray C; Freeman A; Mauch P; Anderson KC; Nadler LM; Ritz J
Bone Marrow Transplant; 1998 Jun; 21(12):1177-81. PubMed ID: 9674848
[TBL] [Abstract][Full Text] [Related]
17. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.
Bird JM; Luger S; Mangan P; Edelstein M; Silberstein L; Powlis W; Ball J; Schultz DJ; Stadtmauer EA
Bone Marrow Transplant; 1996 Aug; 18(2):309-13. PubMed ID: 8864439
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
Friedberg JW; Neuberg D; Gribben JG; Mauch P; Anderson KC; Soiffer RJ; Takvorian T; Fisher DC; Schlossman R; Jallow H; Kuhlman C; Ritz J; Freedman AS
Biol Blood Marrow Transplant; 1999; 5(4):262-8. PubMed ID: 10465106
[TBL] [Abstract][Full Text] [Related]
19. [Autologous bone marrow transplantation in pediatric cancer].
Ohira M
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
[TBL] [Abstract][Full Text] [Related]
20. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
Blystad A; Kvalheim G; Torlakovic E; Holte H; Jacobsen E; Beiske K; Vâlerhaugen H; Lenschow E; Kvaloy S
Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
